IP Library Granted Patent US 9,408,994
Granted Patent B2
US 9,408,994 · App. 14/270,260 · Granted Aug 9, 2016

Conversion of nitrogen dioxide (NO

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,994
App. No.
14/270,260
Granted
Aug 9, 2016
Kind
B2
Abstract

A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.

Claims (25)

1. A method for delivering a therapeutic gas including nitric oxide to a mammal comprising:

introducing an air flow into a delivery system, wherein the air flow has a flow rate of between 5 and 60 liters per minute;

releasing a gas including nitrogen dioxide from a gas source via a pressure regulator;

diffusing the gas including nitrogen dioxide into the air flow, thereby forming an air flow including nitrogen dioxide;

introducing the air flow including nitrogen dioxide into a receptacle including an inlet, an outlet and an antioxidant;

converting the nitrogen dioxide to nitric oxide gas by contacting the nitrogen dioxide with the antioxidant; and

delivering the nitric oxide gas to the mammal in the air flow.

2. The method of claim 1 , wherein the air flow has a flow rate of 5 liters per minute.

3. The method of claim 1 , wherein the pressure regulator diffuses the gas including nitrogen dioxide into the air flow.

4. The method of claim 1 , wherein the pressure regulator includes a diffusion cell.

5. The method of claim 4 , wherein the diffusion cell is made of stainless steel or plastic.

6. The method of claim 4 , wherein the diffusion cell is coupled to at least one needle from which the gas including nitrogen dioxide is released.

7. The method of claim 6 , wherein each needle is connected to a permeation tube.

8. The method of claim 1 , wherein the pressure regulator includes a permeation tube.

9. A method for delivering a therapeutic gas including nitric oxide to a mammal comprising:

introducing an air flow into a delivery system, wherein the air flow has a flow rate of between 5 and 60 liters per minute;

releasing a gas including nitrogen dioxide from a gas source via a diffusion cell or a permeation tube;

diffusing the gas including nitrogen dioxide into the air flow, thereby forming an air flow including nitrogen dioxide;

introducing the air flow including nitrogen dioxide into a receptacle including an inlet, an outlet and an antioxidant;

converting the nitrogen dioxide to nitric oxide gas by contacting the nitrogen dioxide with the antioxidant; and

delivering the nitric oxide gas to the mammal in the air flow.

10. The method of claim 9 , wherein the air flow has a flow rate of 5 liters per minute.

11. The method of claim 9 , wherein the diffusion cell is made of stainless steel or plastic.

12. The method of claim 9 , wherein the diffusion cell is coupled to at least one needle from which the gas including nitrogen dioxide is released.

13. The method of claim 9 , wherein each needle is connected to a permeation tube.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Jun 6, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 046304/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2015
From: FINE, DAVID H.; ROUNBEHLER, DAVID P.; VASQUEZ, GREGORY; JOHNSON, BRYAN
To: GENO LLC
Reel/Frame 035669/0066 →